Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Deloitte
Healthtrust
Mallinckrodt
Boehringer Ingelheim
Farmers Insurance
QuintilesIMS
Covington
Accenture
AstraZeneca

Generated: August 23, 2017

DrugPatentWatch Database Preview

Febuxostat - Generic Drug Details

« Back to Dashboard

What are the generic sources for febuxostat and what is the scope of febuxostat freedom to operate?

Febuxostat
is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in one NDA. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Febuxostat has ninety-three patent family members in thirty-five countries.

There are twenty-three drug master file entries for febuxostat. Four suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: febuxostat

Tradenames:1
Patents:5
Applicants:1
NDAs:1
Drug Master File Entries: see list23
Suppliers / Packagers: see list4
Bulk Api Vendors: see list85
Clinical Trials: see list55
Patent Applications: see list254
Drug Prices:see low prices
DailyMed Link:febuxostat at DailyMed

Pharmacology for Ingredient: febuxostat

Tentative approvals for FEBUXOSTAT

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe40MGTABLET;ORAL
► Subscribe► Subscribe80MGTABLET;ORAL
► Subscribe► Subscribe80MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-002Feb 13, 2009RXYesYes► Subscribe► Subscribe ► Subscribe
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-001Feb 13, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-001Feb 13, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-002Feb 13, 2009RXYesYes► Subscribe► Subscribe ► Subscribe
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-002Feb 13, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: febuxostat

Country Document Number Estimated Expiration
Denmark1956015► Subscribe
China1275126► Subscribe
Canada2812034► Subscribe
Spain2371786► Subscribe
Hong Kong1029788► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: FEBUXOSTAT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0022France► SubscribePRODUCT NAME: FEBUXOSTAT; REGISTRATION NO/DATE: EU/1/08/447/001-004 20080421
00447Netherlands► SubscribePRODUCT NAME: FEBUXOSTAT; REGISTRATION NO/DATE: EU/1/08/447/001-004 20080421
2010 00015Denmark► Subscribe
5Finland► Subscribe
/2010Austria► SubscribePRODUCT NAME: FEBUXOSTAT IN DER KRISTALLFORM A; REGISTRATION NO/DATE: EU/1/08/447/001-004 20080421
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Citi
Cantor Fitzgerald
Daiichi Sankyo
Colorcon
Farmers Insurance
Accenture
Harvard Business School
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot